Dermapharm Holding SE buy Covacoro
Summary
This prediction ended on 25.03.24 with a price of €33.08. The prediction for Dermapharm Holding SE disappointed with a performance of -19.28%. Covacoro has 80% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Dermapharm Holding SE | -3.438% | -3.438% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
According to Covacoro what are the pros and cons of Dermapharm Holding SE for the foreseeable future?
Pros
Cons
Comments by Covacoro for this prediction
In the thread Dermapharm Holding SE diskutieren
In the thread Trading Dermapharm Holding SE
Stopped prediction by Covacoro for Dermapharm Holding SE
Dermapharm Holding SE
28.07.23
29.07.24
05.08.23
Dermapharm Holding SE
18.04.23
18.04.24
24.06.23
Dermapharm Holding SE
14.04.23
14.05.23
15.04.23
Dermapharm Holding SE
29.12.22
29.12.23
07.01.23